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TUBAL FACTOR AS ONE OF THE LEADING FACTORS OF FEMALE INFERTILITY
Infertility is one of the most urgent problems of today, as this condition makes it impossible for a mature organism to produce 
offspring. The issue of restoring and maintaining reproductive health is one of the priority issues of modern gynecology and repro-
ductive medicine. The article adduces the main etiological and pathogenetic links of tubal-peritoneal infertility, as well as briefly 
presents modern views on the diagnosis and treatment of women in this group.
Conclusion. The analysis of current data on the treatment of tubal obstruction will provide an opportunity to more rationally 
address the issue of choosing to restore their patency.
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ТРУБНЫЙ ФАКТОР КАК ОДИН ИЗ ВЕДУЩИХ ФАКТОРОВ ЖЕНСКОГО БЕСПЛОДИЯ
Бесплодие является одной из наиболее актуальных проблем, поскольку данное состояние делает невозможным спо-
собность зрелого организма давать потомков. Вопрос восстановления и сохранения репродуктивного здоровья является 
одной из приоритетных проблем современной гинекологии и репродуктологии. В статье освещены основные этиологиче-
ские и патогенетические звенья трубно-перитонеального бесплодия, а также кратко представлены современные взгляды 
на диагностику и лечение женщин данной группы.
Вывод. Представленный в статье анализ современных данных по лечению трубной непроходимости даст возможность 
более рационально решать вопросы выбора восстановления их проходимости.
Ключевые слова: трубный фактор; бесплодие; вспомогательные репродуктивные технологии.
ТРУБНИЙ ФАКТОР ЯК ОДИН ІЗ ПРОВІДНИХ ЧИННИКІВ ЖІНОЧОГО БЕЗПЛІДДЯ
Безпліддя є однією з найбільш актуальних проблем сьогодення, оскільки даний стан унеможливлює здатність зрілого 
організму давати нащадків. Питання відновлення та збереження репродуктивного здоров’я є однією із пріоритетних проблем 
сучасної гінекології та репродуктології. У статті висвітлено основні етіологічні й патогенетичні ланки трубно-перитонеального 
безпліддя, а також коротко представлено сучасні погляди на діагностику та лікування жінок даної групи.
Висновок. Проведений аналіз сучасних даних щодо лікування трубної непрохідності дасть можливість раціональніше 
вирішувати питання вибору відновлення їх прохідності.
Ключові слова: трубний фактор; безпліддя; допоміжні репродуктивні технології.
Infertility is a complex medical and social problem that has 
been one of the most urgent in modern obstetrics, gynecology 
and reproductive medicine for many years [1]. According to the 
WHO, the frequency of infertile marriages ranges from 8 to 30 % 
and does not tend to decrease in all countries. In Ukraine, the 
frequency of infertile marriage among married couples of repro-
ductive age is more than 15 %, in some regions this figure is close 
to 20 % – a level that is defined as critical and has a negative 
impact on demographics [2]. The cause of infertile marriage in 
40–50 % of cases is the pathology of the reproductive system 
in one of the partners, less often – in 25–30 % – in both [3, 4]
According to WHO recommendations, infertility should 
be predicted and examination and treatment of patients 
should be started immediately if there is no pregnancy within 
12 months of active sexual life in patients under 35 years, 
within 6 months in patients after 35 years, in men over 40 
years [5]. Diseases of the fallopian tubes in the structure of 
female infertility are 29.5–83 % [3, 6].
In primary infertility, the incidence of fallopian tubes is 
28.5–71 %, in secondary infertility – 43–83.1 % [7]. Factors 
of secondary infertility include gynecological surgery history; 
complications after abortion; inflammatory diseases of the 
pelvic organs, age and improper lifestyle.
The main cause of tubal infertility is considered to be 
inflammatory diseases history of the female genital organs 
and sexually transmitted infections, which lead to complete 
or partial obstruction of the tubes due to irreversible damage 
to the cylindrical epithelium of the fallopian tubes, wall 
obliteration, infiltration, flexure due to peritubular and ovarian 
adhesions [8]. The reasons for the formation of partial or 
complete violation of the patency of the fallopian tubes also 
includes the adhesion process. [9]
Surgical interventions on the pelvic organs and abdominal 
cavity, by laparotomy, are a high risk group for the formation of 
tubal infertility [3]. According to the WHO, unilateral or bilateral 
occlusion of the fallopian tubes can occur in 15 % of patients 
after appendectomy, in 60–80 % of patients after ovarian sur-
gery, conservative myomectomy, due to tubal pregnancy [9].
In the structure of tubal-peritoneal infertility, the tubular 
factor is 29.5–83 %, and the peritoneal form of infertility is 
observed in 9.2–34 % [10]. In patients with tubal-peritoneal 
infertility for more than 4 years in the presence of tubal 
patency, only peritoneal infertility was found in 58–70.5 % 
of cases. Tubal-peritoneal infertility occurs in 30–32.7 % of 
patients with PCOS [10].
After a single episode of salpingitis, fallopian tube ob-
struction occurs in 11–13 %, after a double – in 23–36 %, 
when three or more exacerbations – in 54–75 % of cases 
[10]. In 43 % of women who have suffered from inflamma-
tory diseases of the uterine appendages, there is complete 
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obstruction of the fallopian tubes, and in 49 % of cases – 
partial. [12]
Adhesions that occur after the primary inflammatory le-
sion of the fallopian tubes disrupt the mechanisms of capture 
and transport of the egg [7].
Tubal factor infertility occurs when a sperm cannot enter 
the fallopian tube and then the ovary to fertilize an egg, or it 
is impossible for a fertilized embryo to enter the uterus. The 
fallopian tubes connect the ovaries to the uterus on two sides.
Tubal infertility is divided into two types: voluntary – as 
a consequence of sterilization of tubes, and forced – as a 
consequence of tube disease and their partial or complete 
obstruction. In turn, the forced is divided into proximal – the 
obstruction of the tube closer to the uterus. According to 
the ASRM, proximal tubal occlusion is from 10 % to 25 % of 
tube diseases and is usually a relatively mild condition for 
treatment. Distal – obstruction closer to the ovary, as well as 
complete obstruction of the fallopian tubes [13].
Fimbria is a finger-shaped edging of tissue that helps 
an unfertilized egg enter the fallopian tube. Damage to the 
fimbriae can prevent the egg from passing from the ovary 
into the fallopian tubes.
Damage to the fallopian tube and tubal factor infertility are 
common consequences of the upper genital tract infection – 
Chlamydia trachomatis. This pathogen has a direct cytotoxic 
effect on the mucous membrane of the human fallopian tube, 
which leads to loss of microvilli and disruption of cellular con-
nections associated with the rupture of epithelial cells [14].
Histological examination of the fallopian tubes and 
endometrium in patients with tubal-peritoneal infertility of 
inflammatory origin reveals the accumulation of acidic and 
neutral mucopolysaccharides, small-point infiltrates along 
the vessels, "lymphoid aggregates" in the endometrium. Re-
structuring of microcirculation in the fallopian tubes in patients 
with tubal-peritoneal infertility of inflammatory origin in the 
first 2 years is characterized by the development of arteriole 
sclerosis, blood bypass, venules hypertrophy. The result is 
atrophy of the smooth muscle cells of the fallopian tubes, 
sclerosis of the venule wall, leading to decompensation of 
venous blood flow and varicose veins in the isthmic part of 
the fallopian tubes. Sometimes in tubal-peritoneal infertility 
of inflammatory genesis, immunological homeostasis is vio-
lated, and antibodies to uterine, fallopian tube, and ovarian 
tissues appear [10].
Recommendations for selecting a method for diagnosing 
fallopian tubes in patients with tubal infertility initially include 
a baseline assessment with chlamydial antibody testing and 
tuberculin polymerase chain reaction (TBPCR) in endemic 
areas with a high prevalence of the disease [10].
Briceag I. and Costache A. et al (2015) suggest that if 
tubal infertility is suspected, women who do not know if they 
have comorbidities should be offered hysterosalpingography 
as an initial screening test; alternatively, hysterosalpingog-
raphy should be replaced by hysterosalpingo-contrast-ultra-
sonography – it is a fluoroscopic visualization of the uterine 
cavity and fallopian tubes by injection of radiopaque contrast 
agents. Tubal spasm is to blame for the lower accuracy of 
this diagnostic technique, but with the use of intravenous 
scopalamine and patient rotation, it was minimized [15].
This method allows detecting malformations and hypoplasia 
of the uterus, hyperplastic processes of the endometrium, 
adhesions in the pelvis. 
However, Ngowa J. D, Kasia J. M. et al (2015) after a 
number of studies state that hysterosalpingography has 
limited diagnostic value in tubal factor infertility and has 
low diagnostic value for pelvic adhesions. It is believed that 
laparoscopy should be performed in cases of abnormal 
hysterosalpingograms and even in cases of normal hystero-
salpingograms in the context of unexplained infertility [16].
Laparoscopic chromopertubation remains the gold 
standard in assessing tube patency. By injection of diluted 
indigo carmine is injected into the uterine cavity with 
simultaneous laparoscopy to visualize the filling of the tubes 
and effusion into the abdomen. The disadvantages of this 
procedure are: cost, invasiveness and analgesia [15]. During 
laparoscopic intervention, it should be taken into account that 
under the influence of bipolar coagulation there is a premature 
attenuation of ovarian function due to protein denaturation (the 
initial stage of denaturation begins with heating the ovarian 
tissues to a temperature of 45 ° C). This situation leads to a 
decrease in ovarian reserve at a young age of patients [17].
Today, the method of mechanical clipping of the proximal 
part of the fallopian tubes is used, but the disadvantage is 
that the volume of inflammatory exudate can increase due 
to the lack of drainage [17].
The problem of treatment of patients suffering from 
tubal infertility does not lose its relevance, despite the wide 
arsenal of drugs and significant progress in the use of 
endoscopic techniques of adhesiolysis and restoration of 
fallopian tubes. [7]
There are two main methods of treating tubal factor 
infertility – surgical and conservative therapy to repair a 
damaged tube. If these methods are not effective, IVF is 
usually performed to achieve pregnancy.
The most effective drugs for conservative treatment are 
the etiological therapy of chlamydia – tetracycline antibiotics, 
erythromycin and amoxicillin. In case of torpid and chronic 
processes, nonspecific immunotherapy is prescribed. 
According to the indications, local therapy with antiseptic 
solutions is prescribed. Patients are monitored for healing 
2 weeks after the end of antibiotic therapy, then the patient 
is monitored for 3 months with clinical and laboratory tests 
once a month. Parallel examination and treatment of the 
sexual partner is necessary. It is recommended to treat 
uncomplicated anogenital infections with the following 
drugs – Doxycycline 100 mg orally twice a day for 7 days, or 
Azithromycin 1 g orally in one dose. Alternatively, Amoxicillin 
500 mg orally three times daily for 7 days; Erythromycin 500 
mg orally four times a day for 7 days; Ofloxacin 300 mg orally 
twice daily for 7 days or Tetracycline 500 mg orally four times 
daily for 7 days [18].
According to the Special Committee of the World 
Congress on Fertility and Infertility, in infertility due to 
obstruction of the fallopian tubes, the following types 
of surgery are performed: salpingolysis, fimbrioplasty, 
salpingostomy (salpingoneostomy), anastomosis, 
anastomosis, implantation, and combination surgery [19].
Surgical correction is performed in the first phase of 
the menstrual cycle in order to provide optimal conditions 
for tissue regeneration and the possibility of rehabilitation 
measures.
Types of laparoscopic reconstructive plastic surgery:
– salpingoneostomy – restoration of patency of the fimbrial 
uterine tube with its complete occlusion. Birth rates after 
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salpingoneostomy were 20–30 % with an increase to 40 % 
after 50 months of supervision. Retrospective data suggest 
that most pregnancies occur 12–24 months after surgery [20].
– fimbrioplastic is used in the narrowing of the fimbrial 
uterine tube or its partial obstruction by a fibrous ring;
– ovariolysis – dissection of adhesions that create 
obstruction of the ovary. 
– salpingolysis – dissection of adhesions surrounding the 
fallopian tube. This intervention was first performed in 1884. 
Now this operation is the most common. Surgical correction 
of peritubal adhesions, with minimal access, is recommended 
during the adhesion process of stage I-II and in the absence 
of distal occlusion of the fallopian tubes. Randomized surveys 
show that the probability of successful outcomes of tubal 
surgery, including the separation of adhesions, is reduced 
by the severity of the pathological process, being more ef-
fective than without surgery, 67 % compared with 24 % when 
stage 1, 41 % compared with 10 % when stage II and 12 % 
compared to 3 % (unreliable) when stage III disease under 
observation for three years after surgery [20]. 
– uterine tube plastic surgery (English - reconstruction of 
uterine tube) – reconstruction and restoration of the integrity 
of the fallopian tube;
– salpingectomy – surgical removal of one or both 
fallopian tubes [13]. It is important during the preparation 
of a woman for ART, if there is a need for surgical removal 
of the fallopian tubes during laparotomy, it is necessary to 
perform a tubectomy proximal to the body of the uterus to 
avoid ectopic pregnancy in the cult of the fallopian tube 
during embryo transfer.
Salpingoanastomosis is a resection of a tube in which 
a narrowed or obliterated tube is excised, this manipulation 
is performed in cases where obstruction has formed in the 
isthmic part of the tube in the presence of patency in the 
ampullary and interstitial region. The tube on the polyethylene 
pipe is sewn “end to end”.
According to Gary S. Berger, John M. et al. (2016), the 
overall rate of total pregnancy after salpingo-anastomosis 
was 69 %. The overall birth rate was 35 % [21].
The percentage of pregnancy in women after surgery 
depends on many factors and is 18–57 %. Pregnancy 
occurred after salpingostomy and fimbrioplasty in 72 % 
of patients who had only periovarial fusion, in 67 % – 
only peritubular adhesions, in 35–50 % – peritubular 
and periovarial adhesions and 10–26 % of patients had 
hydrosalpinx [19].
At the present stage in the fight against tubal infertility, 
increasing preference is given to assisted reproductive 
technologies. The method of infertility treatment, based 
on in vitro fertilization of eggs and transfer of embryos to 
the uterus, made a revolutionary overthrow in the field of 
reproduction [19].
More than 99 % of ART procedures are IVF. Because the 
ART procedure consists of several stages over an interval 
of about 2 weeks, the procedure is often referred to as the 
treatment cycle [22].
To date, there are three main methods of assisted 
reproductive technologies: 1) intrauterine insemination 
(IUI); 2) in vitro fertilization (IVF); 3) intracytoplasmic sperm 
injection (ICSI).
IUI – specially prepared sperm are injected into the uterus 
when ovulation is expected. IVF – after mixing sperm and 
oocytes, fertilization and initial fragmentation take place in a 
laboratory in special media. ICSI is the injection of a single 
sperm directly into the cytoplasm of an oocyte for fertiliza-
tion [23].
The main indications for in vitro fertilization include severe 
fallopian tube disorders, bilateral salpingectomy.
In the IVF program, oocytes obtained under ultrasound 
control from ovarian follicles in cycles of controlled ovulation 
stimulation and specially prepared sperm are combined in 
the laboratory. Fertilization occurs outside the body. At dif-
ferent stages of fragmentation of fertilized oocytes they are 
transferred to the uterus (ET – embryo transfer) to wait for 
pregnancy [23].
The frequency of pregnancy after IVF – embryo transfer is 
within 30 %. According to the literature data, among pregnan-
cies resulting from IVF, 35 % are multiple. At the same time, 
in 24–28 % of cases, twins were noted, in 4–6 % – triplets, 
and in 0.6 % – more fetuses [24].
The results of IVF and fallopian tube surgery are difficult 
to compare because the results vary depending on the quali-
fications of the surgeon and the human reproduction clinic. 
One randomized study showed that the surgeon as a first 
line of treatment is associated with lower costs and a higher 
overall incidence of pregnancy. Surgical preparation for IVF 
has several purposes. First, the elimination of the negative 
impact of hydrosalpinx on the processes of embryogenesis. 
Second, reducing the risk of ectopic pregnancy during IVF. 
Third, the elimination of pathology of the pelvic organs, which 
can adversely affect the results of IVF. However, the analysis 
shows that the onset of pregnancy after tubal surgery com-
pared to IVF remains unknown – there are no randomized 
controlled trials comparing IVF with tubal surgery [25].
Other current data show that the active implementation of 
large-scale tubal operations before any IVF cycle will reduce 
up to 30 % of the costs associated with gaining viability in 
cases of tube factor sterility [15].
Prevention of tubal factor infertility is the timely detection 
of patients with chlamydia, gonorrhea, trichomoniasis and 
other sexually transmitted diseases, adequate treatment 
of carriers and their sexual partners, implementation of 
extensive health education among the population, especially 
among young people. Personal prevention comes down 
to avoiding casual sex, using condoms, female condoms, 
gel-based microbicides, vaginal rings, films and nanofibers, 
and if an infection is suspected, one must see a doctor 
immediately [26].
Sexually transmitted infections are still part of the global 
health crisis. Fighting it cannot succeed only with treatment, 
timely prevention is needed [26].
CONCLUSIONS. Today, the tubal factor is one of the 
main factors of infertility. In obstetrics and gynecology, there 
are many modern methods of diagnosis and treatment of 
this pathology, both conservative and surgical, but the main 
direction to prevent tubal-peritoneal infertility is personal 
prevention, which avoids accidental sexual contact, use 
of contraception, early detection and adequate treatment 
of inflammatory diseases of the female genital organs and 
sexually transmitted infections. If possible, avoid surgical 
interventions due to further formation of the adhesion pro-
cess. The analysis of current data on the treatment of tubal 
obstruction will make it possible to more rationally solve 
the issue of choosing to restore their patency.
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PROSPECTS FOR FURTHER RESEARCH. In order to 
improve the results of tubal infertility treatment, the priority 
ways are: development of new modern diagnostic methods, 
improving the effectiveness of treatment of women, improv-
ing various types of surgical treatment, diseases of this 
group of patients, use of assisted reproductive technologies 
and their widespread implementation after unsuccessful 
surgical treatment.
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